Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 25, 2010
Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapyKyoung Ha Kim, In-Gu Do, Hyeong Su Kim, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2008
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancerKyoung Ha Kim, Young Suk Park, Myung Hee Chang, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2009
Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancerMyung Hee Chang, Kyoung Ha Kim, Hyun Jung Jun, et al.
Cancer Chemotherapy and Pharmacology|October 8, 2008
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancerSeong Yoon Yi, Young Suk Park, Hyo Song Kim, et al.
BMC Cancer|April 11, 2009
A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancerSang Hoon Ji, Do Hyoung Lim, Seong Yoon Yi, et al.
Anti-Cancer Drugs|October 16, 2009
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancerHyo Song Kim, Seong Yoon Yi, Hyun Jung Jun, et al.
Journal of Cancer|June 22, 2016
Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional ExperienceYoon Jung Oh, Seong Yoon Yi, Ki Hyang Kim, et al.
Nature Communications|August 8, 2018
A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastineHyun Jung Jun, Vicky A Appleman, Hua-Jun Wu, et al.
Annals of Hematology|September 13, 2013
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patientsKihyun Kim, Seok Jin Kim, Verena Voelter, et al.
Pageof 6